Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The current public-health risk is low, but the CDC is working with states to monitor people with animal exposure.

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top ...

The version of the virus spreading in North America right now has led to only a few serious cases, but concerns have been ...

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...

Moderna (MRNA) shares jumped more than 10% ... Louisiana's report that a person previously hospitalized with severe avian influenza A (H5N1) illness [had] passed away." The agency added that ...

In July 2024, Moderna was awarded $176 million from the US government to advance the development of its mRNA H5N1 (bird flu) vaccine, which is in the early stages of testing. The award came after ...